VEEV vs. PFE
VEEV (Veeva Systems Inc.) and PFE (Pfizer Inc.) are both stocks. Both are in the Healthcare sector — VEEV in Health Information Services, PFE in Drug Manufacturers - General. Over the past 10 years, VEEV returned 16.73%/yr vs 2.11%/yr for PFE. At a 0.20 correlation, their price movements are largely independent.
Performance
VEEV vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VEEV achieves a -28.53% return, which is significantly lower than PFE's 8.79% return. Over the past 10 years, VEEV has outperformed PFE with an annualized return of 16.73%, while PFE has yielded a comparatively lower 2.11% annualized return.
VEEV
- 1D
- -1.24%
- 1M
- 2.11%
- YTD
- -28.53%
- 6M
- -28.54%
- 1Y
- -43.54%
- 3Y*
- -5.80%
- 5Y*
- -11.82%
- 10Y*
- 16.73%
PFE
- 1D
- 0.15%
- 1M
- 1.79%
- YTD
- 8.79%
- 6M
- 4.79%
- 1Y
- 14.27%
- 3Y*
- -7.78%
- 5Y*
- -3.35%
- 10Y*
- 2.11%
VEEV vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VEEV Veeva Systems Inc. | -28.53% | 6.17% | 9.21% | 19.30% | -36.83% | -6.16% | 93.55% | 57.48% | 61.58% | 35.82% |
PFE Pfizer Inc. | 8.79% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between VEEV and PFE is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Oct 16, 2013 | 0.20 |
The correlation between VEEV and PFE shifts across timeframes, from 0.07 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.
Fundamentals
VEEV:
$26.48B
PFE:
$150.21B
VEEV:
$5.63
PFE:
$1.31
VEEV:
28.36
PFE:
19.98
VEEV:
1.47
PFE:
0.36
VEEV:
8.04
PFE:
2.36
VEEV:
3.63
PFE:
1.67
VEEV:
$3.32B
PFE:
$63.32B
VEEV:
$2.49B
PFE:
$43.91B
VEEV:
$1.00B
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VEEV vs. PFE — Risk / Return Rank
VEEV
PFE
VEEV vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Veeva Systems Inc. (VEEV) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VEEV | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.76 | ||
| Sortino ratioReturn per unit of downside risk | -2.87 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 1.12 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.86 | 1.13 | -1.99 |
| Martin ratioReturn relative to average drawdown | -1.51 | 2.27 | -3.79 |
Loading charts...
Drawdowns
VEEV vs. PFE - Drawdown Comparison
The maximum VEEV drawdown since its inception was -61.35%, smaller than the maximum PFE drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for VEEV and PFE.
Loading charts...
Drawdown Indicators
| VEEV | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.35% | -69.24% | +7.89% |
Max Drawdown (1Y)Largest decline over 1 year | -50.55% | -11.47% | -39.08% |
Max Drawdown (3Y)Largest decline over 3 years | -50.55% | -40.43% | -10.12% |
Max Drawdown (5Y)Largest decline over 5 years | -55.69% | -58.96% | +3.27% |
Max Drawdown (10Y)Largest decline over 10 years | -55.69% | -58.96% | +3.27% |
Current DrawdownCurrent decline from peak | -53.21% | -45.68% | -7.53% |
Average DrawdownAverage peak-to-trough decline | -26.08% | -22.90% | -3.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.76% | 5.70% | +23.06% |
Volatility
VEEV vs. PFE - Volatility Comparison
Veeva Systems Inc. (VEEV) has a higher volatility of 14.08% compared to Pfizer Inc. (PFE) at 5.07%. This indicates that VEEV's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VEEV | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.08% | 5.07% | +9.01% |
Volatility (6M)Calculated over the trailing 6-month period | 29.27% | 14.62% | +14.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.87% | 23.84% | +12.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.98% | 25.48% | +12.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.23% | 23.89% | +14.34% |
Dividends
VEEV vs. PFE - Dividend Comparison
VEEV has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 6.56% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
VEEV Veeva Systems Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
VEEV vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Veeva Systems Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VEEV vs. PFE - Profitability Comparison
VEEV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported a gross profit of 659.69M and revenue of 882.95M. Therefore, the gross margin over that period was 74.7%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
VEEV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported an operating income of 273.11M and revenue of 882.95M, resulting in an operating margin of 30.9%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
VEEV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported a net income of 260.94M and revenue of 882.95M, resulting in a net margin of 29.6%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
VEEV and PFE have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VEEV has higher volatility (14.08%) compared to PFE (5.07%). In terms of maximum drawdown, VEEV dropped -61.35% vs PFE's -69.24%.
PFE currently has the higher Sharpe Ratio (0.54 vs -1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VEEV and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer